ReportWire

Tag: Medical research

  • AI wearable helps stroke survivors speak again

    [ad_1]

    NEWYou can now listen to Fox News articles!

    Losing the ability to speak clearly after a stroke can feel devastating. For many survivors, the words are still there in their minds, but their bodies will not cooperate. Speech becomes slow, unclear or fragmented. This condition, known as dysarthria, affects nearly half of all stroke survivors and can make everyday communication exhausting. Now, researchers believe they may have found a better way forward. Scientists at the University of Cambridge have developed a wearable device called Revoice. It is designed to help people with post-stroke speech impairment communicate naturally again without surgery or brain implants.

    Sign up for my FREE CyberGuy Report

    Get my best tech tips, urgent security alerts, and exclusive deals delivered straight to your inbox. Plus, you’ll get instant access to my Ultimate Scam Survival Guide — free when you join my CYBERGUY.COM newsletter.

    FULLY IMPLANTABLE BRAIN CHIP AIMS TO RESTORE REAL SPEECH

    A soft, flexible choker like this houses Revoice’s sensors, which read subtle throat vibrations to help reconstruct speech in real time. (University of Cambridge)

    Why dysarthria makes recovery so hard

    Dysarthria is a physical speech disorder. A stroke can weaken the muscles in the face, mouth and vocal cords. As a result, speech may sound slurred, slow or incomplete. Many people can only say a few words at a time, even though they know exactly what they want to say. According to professor Luigi Occhipinti, that disconnect creates deep frustration. Stroke survivors often work with speech therapists using repetitive drills. These exercises help over time, but open-ended conversation remains difficult. Recovery can take months or even longer, which leaves patients struggling during daily interactions with family, caregivers and doctors.

    How the Revoice device works

    Revoice takes a very different approach. Instead of asking users to type, track their eyes or rely on implants, the device reads subtle physical signals from the throat and neck. It looks like a soft, flexible choker made from breathable, washable fabric. Inside are ultra-sensitive textile strain sensors and a small wireless circuit board. When a user silently mouths words, the sensors detect tiny vibrations in the throat muscles. At the same time, the device measures pulse signals in the neck to estimate emotional state.

    Those signals are processed by two artificial intelligence (AI) agents:

    • One reconstructs words from mouthed speech
    • The other interprets emotion and context to build complete sentences

    Together, they allow Revoice to turn a few mouthed words into fluent speech in real time.

    ELON MUSK SHARES PLAN TO MASS-PRODUCE BRAIN IMPLANTS FOR PARALYSIS, NEUROLOGICAL DISEASE

    A diagram of how the Revoice device works on a patient

    This diagram shows how Revoice combines throat muscle signals and pulse data with AI to turn silently mouthed words into full, expressive sentences in real time. (University of Cambridge)

    Why this AI approach is different

    Earlier silent speech systems had serious limits. Many were tested only on healthy volunteers. Others forced users to pause for several seconds between words, which made the conversation feel unnatural. Revoice avoids those delays. It uses an AI-driven throat sensor system paired with a lightweight language model. Because the model runs efficiently, it uses very little power and delivers near-instant responses. The device is powered by a 1,800 mWh battery, which researchers expect will last a full day on a single charge.

    What early trials revealed

    After refining the system with healthy participants, researchers tested Revoice with five stroke patients who had dysarthria.

    The results were striking:

    • Word error rate: 4.2%
    • Sentence error rate: 2.9%

    In one example, a patient mouthed the phrase “We go hospital.” Revoice expanded it into a complete sentence that reflected urgency and frustration, based on emotional signals and context. Participants reported a 55% increase in satisfaction and said the device helped them communicate as fluently as they did before their stroke.

    PARALYZED MAN WALKS AGAIN AFTER EXPERIMENTAL DRUG TRIAL TRIGGERS REMARKABLE RECOVERY

    This figure breaks down the Revoice hardware and AI pipeline, showing how strain sensors, wireless electronics, and emotion decoding work together to reconstruct natural speech.

    This figure breaks down the Revoice hardware and AI pipeline, showing how strain sensors, wireless electronics, and emotion decoding work together to reconstruct natural speech. (University of Cambridge)

    Beyond stroke recovery

    Researchers believe Revoice could also help people with Parkinson’s disease and motor neuron disease. Because the device is comfortable, washable, and designed for daily wear, it could fit into real-world routines rather than being confined to clinics. Before that can happen, larger clinical trials are required. The research team plans to begin broader studies with native English-speaking patients and hopes to expand the system to support multiple languages and a wider range of emotional expressions. The findings were published in the journal Nature Communications.

    What this means for you

    If you or someone you care for has experienced a stroke, this research points to a major shift in recovery tools. Revoice suggests that speech assistance does not need to be invasive to be effective. A wearable solution could support communication during the most difficult months of rehabilitation, when confidence and independence often suffer the most. It may also reduce stress for caregivers who struggle to understand incomplete or unclear speech. Clear communication can improve medical care, emotional well-being and daily decision-making.

    Take my quiz: How safe is your online security?

    Think your devices and data are truly protected? Take this quick quiz to see where your digital habits stand. From passwords to Wi-Fi settings, you’ll get a personalized breakdown of what you’re doing right and what needs improvement. Take my Quiz here: Cyberguy.com

    Kurt’s key takeaways

    Communication is tied closely to dignity and independence. For stroke survivors, losing that ability can be one of the hardest parts of recovery. Revoice shows how artificial intelligence and wearable tech can work together to restore something deeply human. While it is still early, this device represents a meaningful step toward making recovery feel less isolating and more hopeful.

    If a simple wearable could help restore natural speech, should it become a standard part of stroke rehabilitation? Let us know by writing to us at Cyberguy.com

    CLICK HERE TO DOWNLOAD THE FOX NEWS APP

    Sign up for my FREE CyberGuy Report 

    Get my best tech tips, urgent security alerts, and exclusive deals delivered straight to your inbox. Plus, you’ll get instant access to my Ultimate Scam Survival Guide — free when you join my CYBERGUY.COM newsletter. 

    Copyright 2026 CyberGuy.com.  All rights reserved.

    [ad_2]

    Source link

  • ‘It’s a game changer’: Artificial intelligence helps Iowa surgeon reconstruct teen’s jaw

    [ad_1]

    While waiting in a Des Moines, Iowa, exam room, Mya Buie nervously applies her lip gloss. Three months ago, the 17-year-old had multiple surgeries to reconstruct her jaw. In this moment, she is waiting to be seen for a postoperative checkup. She hasn’t liked medical settings since a shooting landed her in a Des Moines hospital’s intensive care unit for several days.”It was kind of scary. It was traumatic,” she said of the night her mother’s ex-boyfriend shot her in the face during a fight just days before her birthday.On the other hand, her surgeon, Dr. Simon Wright, has been looking forward to this appointment all week. He calls Buie one of his most memorable and brave patients.”I’m gonna take a look under your chin,” he says to Buie while carefully touching her face. The teenager was shot in the face with a .40-caliber bullet at close range. The impact of the bullet fractured and shattered her jaw into tiny fragments and permanently damaged four teeth.For years, Wright, a facial reconstruction trauma surgeon, has reconstructed facial bones by bending and molding titanium plates by hand to the injured area. It’s a time-consuming and often erroneous process.”There is always a level of dissatisfaction, and it doesn’t feel good to do something just good enough,” Wright said.The manual work has now been replaced with modern technology. Doctors used artificial intelligence to read a CT scan of Buie’s jaw, then a 3D printer turned that image into a custom jawbone plate.”It’s so much easier than trying to bend a plate to get it perfect,” Wright said. “It’s no question a game-changer.”Doctors say a customized jawbone plate allows for a more accurate fit, better aligns the jaw with a patient’s teeth, and cuts surgery time in half. What makes this process so unique: Buie’s customized plate was made in record time, a first for Des Moines trauma surgeons. “The ability to make a custom plate has been around for 10 years or more, but the ability to do it very quickly has not been,” Wright said.What would normally take several weeks took only a few days. The plate was created in a lab in Jacksonville, Florida, put on a plane to the Des Moines International Airport, then hand-delivered to the hospital on a Friday night before the teenager’s surgery first thing Saturday morning. “There is a lot of things that have to go right to do any kind of surgery at all, and to do something complicated like this, it’s really an inspiring thing to be part of,” Wright said, smiling. He also said this advancement serves as a reminder of the importance of supporting medical research because of its impact on people. “This came from the efforts of all kinds of people in different fields that have cross-pollinated. For example, 3D printing as a medical application, and at one point, it may not have begun with a medical endpoint in mind,” he said.For trauma patients, time is of the essence. For Buie, time does heal. The high school junior is back to school with plans to graduate early. Doctors expect her to make a full recovery. Her new jawbone plate will eventually fuse to bone and be as strong as ever. “I just thank God every day for giving me a second chance at life. I’m very grateful. I can tell my story and spread the word of God with this story, like a testament.” Buie will likely undergo additional surgeries. Next month, she will receive dental implants for her missing teeth.

    While waiting in a Des Moines, Iowa, exam room, Mya Buie nervously applies her lip gloss. Three months ago, the 17-year-old had multiple surgeries to reconstruct her jaw. In this moment, she is waiting to be seen for a postoperative checkup. She hasn’t liked medical settings since a shooting landed her in a Des Moines hospital’s intensive care unit for several days.

    “It was kind of scary. It was traumatic,” she said of the night her mother’s ex-boyfriend shot her in the face during a fight just days before her birthday.

    On the other hand, her surgeon, Dr. Simon Wright, has been looking forward to this appointment all week. He calls Buie one of his most memorable and brave patients.

    “I’m gonna take a look under your chin,” he says to Buie while carefully touching her face. The teenager was shot in the face with a .40-caliber bullet at close range. The impact of the bullet fractured and shattered her jaw into tiny fragments and permanently damaged four teeth.

    For years, Wright, a facial reconstruction trauma surgeon, has reconstructed facial bones by bending and molding titanium plates by hand to the injured area. It’s a time-consuming and often erroneous process.

    “There is always a level of dissatisfaction, and it doesn’t feel good to do something just good enough,” Wright said.

    The manual work has now been replaced with modern technology. Doctors used artificial intelligence to read a CT scan of Buie’s jaw, then a 3D printer turned that image into a custom jawbone plate.

    “It’s so much easier than trying to bend a plate to get it perfect,” Wright said. “It’s no question a game-changer.”

    Doctors say a customized jawbone plate allows for a more accurate fit, better aligns the jaw with a patient’s teeth, and cuts surgery time in half. What makes this process so unique: Buie’s customized plate was made in record time, a first for Des Moines trauma surgeons.

    The ability to make a custom plate has been around for 10 years or more, but the ability to do it very quickly has not been,” Wright said.

    What would normally take several weeks took only a few days. The plate was created in a lab in Jacksonville, Florida, put on a plane to the Des Moines International Airport, then hand-delivered to the hospital on a Friday night before the teenager’s surgery first thing Saturday morning.

    “There is a lot of things that have to go right to do any kind of surgery at all, and to do something complicated like this, it’s really an inspiring thing to be part of,” Wright said, smiling. He also said this advancement serves as a reminder of the importance of supporting medical research because of its impact on people.

    “This came from the efforts of all kinds of people in different fields that have cross-pollinated. For example, 3D printing as a medical application, and at one point, it may not have begun with a medical endpoint in mind,” he said.

    For trauma patients, time is of the essence. For Buie, time does heal. The high school junior is back to school with plans to graduate early. Doctors expect her to make a full recovery. Her new jawbone plate will eventually fuse to bone and be as strong as ever.

    “I just thank God every day for giving me a second chance at life. I’m very grateful. I can tell my story and spread the word of God with this story, like a testament.”

    Buie will likely undergo additional surgeries. Next month, she will receive dental implants for her missing teeth.

    [ad_2]

    Source link

  • Smart pill confirms when medication is swallowed

    [ad_1]

    NEWYou can now listen to Fox News articles!

    Remembering to take medication sounds simple. However, missed doses put people at serious health risk every day. Because of that, engineers at the Massachusetts Institute of Technology (MIT) have designed a pill that confirms when someone swallows it. As a result, doctors could track treatment more accurately, and patients could stay on schedule more easily. At the same time, the pill safely breaks down inside the body, which helps reduce long-term risk.

    Sign up for my FREE CyberGuy Report

    Get my best tech tips, urgent security alerts, and exclusive deals delivered straight to your inbox. Plus, you’ll get instant access to my Ultimate Scam Survival Guide — free when you join my CYBERGUY.COM newsletter.

    FDA CLEARS FIRST AT-HOME BRAIN DEVICE FOR DEPRESSION

    MIT engineers have designed a pill that can report when it has been swallowed. (Mehmet Say)

    How the MIT smart pill works

    The new system fits inside existing pill capsules. It uses a tiny, biodegradable radio-frequency antenna made from zinc and cellulose. These materials already have strong safety records in medicine. Here is what happens step by step:

    • You swallow the capsule as usual
    • The outer coating dissolves in the stomach
    • The pill releases both the medication and the antenna
    • The antenna sends a radio signal confirming ingestion

    This entire process happens within about 10 minutes. An external receiver, potentially built into a wearable device, detects the signal from up to two feet away.

    Designed to break down safely

    Previous smart pill designs relied on components that stayed intact as they passed through the digestive system. That raised concerns about long-term safety. The MIT team took a different approach. Nearly all parts of the antenna break down in the stomach within days. Only a tiny off-the-shelf RF chip remains, and it passes naturally through the body. According to lead researcher Mehmet Girayhan Say, the goal is clear. The system avoids long-term buildup while still reliably confirming that a pill was taken.

    Who could benefit most from this technology?

    This smart pill is not meant for every prescription. Instead, it targets situations where missing medication can be dangerous. Potential beneficiaries include:

    • Organ transplant patients taking immunosuppressants
    • People with chronic infections like TB or HIV
    • Patients with recent stent procedures
    • Individuals with neuropsychiatric conditions

    For these patients, adherence can mean the difference between recovery and serious complications.

    BREAKTHROUGH DEVICE PROMISES TO DETECT GLUCOSE WITHOUT NEEDLES

    Woman hand with pills on, spilling pills out of bottle on dark background.

    The MIT capsule uses layered materials, including gelatin, cellulose, and metals like molybdenum or tungsten, to prevent any RF signal from transmitting outside the body. (iStock)

    What researchers say about the breakthrough pill

    Senior author Giovanni Traverso emphasizes that the focus is on patient health. The aim is to support people, not police them. The research team published its findings in Nature Communications and plans further preclinical testing. Human trials are expected next as the technology moves closer to real-world use. This research received funding from Novo Nordisk, MIT Department of Mechanical Engineering, Brigham and Women’s Hospital Division of Gastroenterology and the U.S. Advanced Research Projects Agency for Health.

    Why medication adherence remains a major problem

    Patients failing to take medicine as prescribed contribute to hundreds of thousands of preventable deaths each year. It also adds billions of dollars to health care costs. This problem hits hardest when patients must take treatment consistently over long periods. That includes people who have received organ transplants, patients with tuberculosis and those managing complex neurological conditions. For these groups, missing doses can have life-altering consequences.

    10 HEALTH TECH PRODUCTS STEALING THE SPOTLIGHT AT CES 2026

    medicine drugs pills

    Once safely inside the stomach, the pill can activate and communicate internally, reducing privacy risks while enabling more accurate medical tracking. (iStock)

    What this means for you

    If you or a loved one relies on critical medication, this kind of technology could add an extra layer of safety. It may reduce guesswork for doctors and ease pressure on patients who manage complex treatment plans. At the same time, it raises important questions about privacy, consent and how medical data is shared. Any future rollout will need strong safeguards to protect patients.

    For now, until this technology becomes available, you can still stay on track by using the built-in tools on your phone. We break down the best ways to track your meds on iPhone and Android in our step-by-step guide.

    Take my quiz: How safe is your online security?

    Think your devices and data are truly protected? Take this quick quiz to see where your digital habits stand. From passwords to Wi-Fi settings, you’ll get a personalized breakdown of what you’re doing right and what needs improvement. Take my Quiz here: Cyberguy.com     

    CLICK HERE TO DOWNLOAD THE FOX NEWS APP

    Kurt’s key takeaways

    A pill that confirms it was swallowed may sound futuristic, but it addresses a very real problem. By combining simple materials with smart engineering, MIT researchers created a tool that could save lives without lingering in the body. As testing continues, this approach could reshape how medicine is monitored and delivered.

    Would you be comfortable taking a pill that reports when you swallow it if it meant better health outcomes? Let us know by writing to us at Cyberguy.com

    Sign up for my FREE CyberGuy Report

    Get my best tech tips, urgent security alerts, and exclusive deals delivered straight to your inbox. Plus, you’ll get instant access to my Ultimate Scam Survival Guide — free when you join my CYBERGUY.COM newsletter. 

    Copyright 2026 CyberGuy.com.  All rights reserved.

    [ad_2]

    Source link

  • Breakthrough device promises to detect glucose without needles

    [ad_1]

    NEWYou can now listen to Fox News articles!

    The idea of tracking blood sugar without needles has challenged health tech for years. For people with diabetes, constant monitoring is critical, yet the tools remain uncomfortable and invasive. Finger pricks hurt. Traditional continuous glucose monitors still sit under the skin. That daily burden adds up fast.

    Recently, one small device has been drawing significant attention for tackling that problem in a very different way.

    Sign up for my FREE CyberGuy Report

    Get my best tech tips, urgent security alerts and exclusive deals delivered straight to your inbox. Plus, you’ll get instant access to my Ultimate Scam Survival Guide — free when you join my CYBERGUY.COM newsletter.

    WEIGHT LOSS EXPERTS PREDICT 5 MAJOR TREATMENT CHANGES LIKELY TO EMERGE IN 2026

    A small breath-based device called isaac aims to alert users to glucose changes without needles or sensors under the skin. (PreEvnt)

    Why noninvasive glucose tracking matters

    Blood sugar levels can rise or fall quickly. When changes go unnoticed, the risks increase, from long-term organ damage to sudden hypoglycemia. Monitoring can be especially difficult for:

    • Small children
    • Older adults
    • Anyone who struggles with needles

    At the same time, glucose tracking has surged among people without diabetes. As GLP-1 medications gain popularity, many people now track their blood sugar to understand how food affects their bodies. The need for simpler tools keeps growing.

    Even Apple has spent years trying to bring no-prick glucose tracking to wearables. Despite heavy investment, the feature has yet to arrive.

    NEEDLE-FREE GLUCOSE CHECKS MOVE CLOSER TO REALITY

    An isaac device

    Instead of finger pricks, the device analyzes acetone and other compounds in exhaled breath linked to blood sugar levels. (PreEvnt)

    How the PreEvnt isaac monitors glucose using breath

    One of the most talked-about health devices at CES 2026 came from PreEvnt. Its product, called isaac, takes a nontraditional approach to glucose awareness. Instead of piercing skin or using optical sensors, isaac analyzes your breath. 

    The device measures volatile organic compounds, especially acetone, which has long been associated with rising blood glucose. That sweet fruity breath is a known marker of diabetes. By detecting changes in those compounds, isaac can alert users to potential glucose events. The device is small, about the size of a quarter, with a loop so it can be worn on a lanyard or clipped to clothing or a bag.

    The breath-based design is intended to reduce how often users need finger-prick blood tests, while providing early alerts for glucose-related changes.

    The device is named after the inventor’s grandson, Isaac, who was diagnosed with Type 1 diabetes at just 2 years old. The inventor, Bud Wilcox, wanted to reduce the number of painful finger pricks his grandson faced each day. That personal motivation led to years of collaboration with scientists, designers and engineers. Research and development included work with Indiana University under the direction of Dr. M. Agarwal. The goal was simple but ambitious: Alert families to blood sugar events earlier while reducing the physical and emotional toll of constant testing.

    How the isaac device fits into daily life

    Isaac is designed to fit into everyday routines. Users breathe into the device, which processes the reading and sends the data to a companion smartphone app. The app, still in its final stages of development, focuses on awareness and safety. Current features include:

    • A timeline for logging meals
    • A history of breath readings
    • Alerts that can notify emergency contacts

    This matters because people with diabetes can become disoriented or incapacitated during hypoglycemic events. Early alerts give caregivers or family members a chance to step in. A single charge lasts all day and supports multiple breath tests. The device comes with a USB-C charging cradle and cable.

    Who isaac is designed for

    According to PreEvnt, isaac is being developed for:

    • Type 1 diabetics
    • Type 2 diabetics
    • Prediabetics

    It may also appeal to people focused on metabolic health. As mentioned, the device is still undergoing development and FDA review and is not yet for sale in the U.S. The companion app will launch on iOS and Android closer to availability.

    TYPE 1 DIABETES REVERSED IN LANDMARK STUDY, PAVING THE WAY FOR HUMAN STUDIES

    An isaac device

    Designed for everyday use, the isaac wearable device pairs with a smartphone app to log readings and send alerts when needed. (PreEvnt)

    Clinical trials and FDA review for the isaac device

    PreEvnt first introduced isaac publicly at CES 2025. Later that year, the device entered active human clinical trials. Those studies compare isaac’s breath-based alerts with traditional blood glucose monitoring methods. 

    Trials began with adolescents who have Type 1 diabetes and later expanded to adults with Type 2 diabetes. The company is now working toward regulatory review with the U.S. Food and Drug Administration. Because this technology is new, PreEvnt is pursuing a de novo pathway, which allows devices to be evaluated while standards are still being defined. According to the company, regulators have shown strong interest as the data continues to come in.

    Isaac does not claim to replace medical-grade glucose meters. The device is being developed to supplement existing monitoring methods by offering breath-based alerts tied to glucose-related changes.

    Take my quiz: How safe is your online security?

    Think your devices and data are truly protected? Take this quick quiz to see where your digital habits stand. From passwords to Wi-Fi settings, you’ll get a personalized breakdown of what you’re doing right and what needs improvement. Take my Quiz here: Cyberguy.com.      

    Kurt’s key takeaways

    Noninvasive glucose monitoring has long felt like a future promise that never quite arrives. The attention around isaac at CES 2026 suggests that promise may finally be getting closer. If clinical trials continue to deliver strong results and regulators give approval, breathing into a small device could one day replace at least some finger pricks. For families living with diabetes, that shift could make daily life easier and safer.

    Would you trust a breath-based device to warn you about rising blood sugar before symptoms appear? Let us know by writing to us at Cyberguy.com

    CLICK HERE TO DOWNLOAD THE FOX NEWS APP

    Sign up for my FREE CyberGuy Report

    Get my best tech tips, urgent security alerts and exclusive deals delivered straight to your inbox. Plus, you’ll get instant access to my Ultimate Scam Survival Guide — free when you join my CYBERGUY.COM newsletter. 

    Copyright 2026 CyberGuy.com.  All rights reserved.

    [ad_2]

    Source link

  • Your sleep and activity patterns may reveal hidden brain health risk, study suggests

    [ad_1]

    NEWYou can now listen to Fox News articles!

    The timing of your sleep patterns could be linked to increased dementia risk, according to a new study.

    Each person’s circadian rhythm, often defined as the body’s internal 24-hour clock, keeps the body operating on a healthy pattern of sleeping and waking. It also affects other systems in your body, according to Cleveland Clinic.

    While most people’s circadian rhythms are automatically regulated, things like light levels can throw them off balance.

    BRAIN HEALTH WARNING SIGN COULD BE HIDING IN PLAIN SIGHT, SAY RESEARCHERS

    People with strong circadian rhythms are usually able to stick to regular times for sleeping and activity, even with schedule or season changes, experts say.

    With a weaker circadian rhythm, light and schedule changes are more likely to disrupt the body clock, leading to shifts in sleep and activity patterns.

    Older adults with weaker daily activity rhythms were more likely to develop dementia over the following years. (iStock)

    The new study, published in the journal Neurology, sought to explore whether these disruptions play a role in dementia risk among older adults.

    Researchers from the Academy of Neurology monitored more than 2,000 people for an average of 12 days to track their rest and rhythm activities.

    CLICK HERE TO DOWNLOAD THE FOX NEWS APP

    “A novel aspect of our study is that we derived circadian rhythms from a chest-worn ECG patch that is commonly used clinically,” lead study author Wendy Wang, Ph.D., of the Peter O’Donnell Jr. School of Public Health at UT Southwestern Medical Center in Dallas, told Fox News Digital.

    SCIENTISTS UNCOVER HOW SOME 80-YEAR-OLDS HAVE THE MEMORY OF 50-YEAR-OLDS

    The participants’ average age was 79, and none had dementia at the time of the study. They were divided into three groups based on the strength of their circadian rhythms.

    In the group with the strongest rhythms, 31 of 728 people developed dementia, compared to 106 of 727 people in the group with the weakest rhythms.

    Heart doctor with patient

    Chest-worn ECG patches monitored patients’ circadian rhythm in the new study. (iStock)

    After adjusting for factors such as age, blood pressure and heart disease, researchers found that people in the weakest rhythm group had nearly 2.5 times the risk of dementia.

    The researchers identified a possible “U-shaped” association between the stability of the sleep-wake cycle and dementia, noting that people with consistently low activity levels may have less stable circadian rhythms.

    CLICK HERE FOR MORE HEALTH STORIES

    People whose activity peaked at 2:15 p.m. or later had a 45% higher risk of dementia compared to those whose activity peaked earlier in the day. About 7% of people in the earlier peak group developed dementia, compared to 10% in the later peak group.

    CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

    The study did have some limitations. Data on sleep disorders, such as obstructive sleep apnea or sleep-disordered breathing, were not available. Wang noted that more research is needed to understand the possible link.

    Man awake at night can't sleep

    With a weaker circadian rhythm, light and schedule changes are more likely to disrupt the body clock, leading to shifts in sleep and activity patterns. (iStock)

    The researcher also recommended that people maintain a strong circadian rhythm that is “well-aligned” with the 24-hour day.

    TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

    “People with strong circadian rhythms often follow regular sleep and activity times,” she said.

    “However, it’s important to note that our research does not prove that irregular circadian rhythms cause dementia, only that an association was observed.”

    [ad_2]

    Source link

  • Florida Panthers enlist stars for unique cancer fundraiser

    [ad_1]

    The Florida Panthers have signed Wayne Gretzky, Martina Navratilova, Michael Bublé, Dustin Johnson, and the Miami Heat for a unique project

    MIAMI — For their latest project, the Florida Panthers signed Wayne Gretzky, Martina Navratilova, Michael Bublé, Dustin Johnson and the Miami Heat.

    And they were armed with paintbrushes, not hockey sticks.

    The Panthers — a few hours before their Winter Classic outdoor game at the Miami Marlins’ ballpark against the New York Rangers — unveiled a couple dozen panther sculptures, all painted in a unique way and now being auctioned off with hopes of raising $1 million for cancer research.

    Gretzky commissioned a sculpture that displays some of his stats, Johnson arranged one depicting a scene from Augusta National, Bublé’s is adorned in rhinestone braille, the NBA’s Heat commissioned a pair of sculptures with some of the team’s themes, artist Romero Britto painted one as well and Navratilova didn’t technically paint hers — she dipped tennis balls into paint and then served them into the panther, creating a polka-dotted splash of various colors.

    “To be able to have the privilege to reach out and make those contacts and have those folks say, ‘Of course,’ what a gift that was,” Panthers general manager and hockey operations president Bill Zito said. “It’s just so neat.”

    About $700,000 has been raised already, Zito said. The idea for the fundraiser — “Panthers on the Prowl,” they call it — is loosely built around Chicago’s “Cows on Parade” art project. Zito and his wife Julie co-chair the Panthers’ project; she is a breast cancer survivor, and Zito has lost a number of relatives to the disease.

    “It was my wife Julie’s idea,” Zito said. “And we lived in Chicago during ‘Cows on Parade,’ and then Romero Britto said we should auction them. I can’t take credit for any of it.”

    Many of the panthers were on display at LoanDepot Park on Friday, where about 35,000 fans attending the Winter Classic would see them.

    “There’s a tear and a smile,” Zito said. “And then you think, you know what, there’s a reason that everybody is engaged. There’s a reason that everybody gave their time and their talent. And it’s because it works and it’s right.”

    ___

    AP NHL: https://apnews.com/hub/nhl

    [ad_2]

    Source link

  • Health subsidies expire, launching millions of Americans into 2026 with steep insurance hikes

    [ad_1]

    NEW YORK — NEW YORK (AP) — Enhanced tax credits that have helped reduce the cost of health insurance for the vast majority of Affordable Care Act enrollees expired overnight, cementing higher health costs for millions of Americans at the start of the new year.

    Democrats forced a 43-day government shutdown over the issue. Moderate Republicans called for a solution to save their 2026 political aspirations. President Donald Trump floated a way out, only to back off after conservative backlash.

    In the end, no one’s efforts were enough to save the subsidies before their expiration date. A House vote expected in January could offer another chance, but success is far from guaranteed.

    The change affects a diverse cross-section of Americans who don’t get their health insurance from an employer and don’t qualify for Medicaid or Medicare — a group that includes many self-employed workers, small business owners, farmers and ranchers.

    It comes at the start of a high-stakes midterm election year, with affordability — including the cost of health care — topping the list of voters’ concerns.

    “It really bothers me that the middle class has moved from a squeeze to a full suffocation, and they continue to just pile on and leave it up to us,” said 37-year-old single mom Katelin Provost, whose health care costs are set to jump. “I’m incredibly disappointed that there hasn’t been more action.”

    The expired subsidies were first given to Affordable Care Act enrollees in 2021 as a temporary measure to help Americans get through the COVID-19 pandemic. Democrats in power at the time extended them, moving the expiration date to the start of 2026.

    With the expanded subsidies, some lower-income enrollees received health care with no premiums, and high earners paid no more than 8.5% of their income. Eligibility for middle-class earners was also expanded.

    On average, the more than 20 million subsidized enrollees in the Affordable Care Act program are seeing their premium costs rise by 114% in 2026, according to an analysis by the health care research nonprofit KFF.

    Those surging prices come alongside an overall increase in health costs in the U.S., which are further driving up out-of-pocket costs in many plans.

    Some enrollees, like Salt Lake City freelance filmmaker and adjunct professor Stan Clawson, have absorbed the extra expense. Clawson said he was paying just under $350 a month for his premiums last year, a number that will jump to nearly $500 a month this year. It’s a strain for the 49-year-old but one he’s willing to take on because he needs health insurance as someone who lives with paralysis from a spinal cord injury.

    Others, like Provost, are dealing with steeper hikes. The social worker’s monthly premium payment is increasing from $85 a month to nearly $750.

    Health analysts have predicted the expiration of the subsidies will drive many of the 24 million total Affordable Care Act enrollees — especially younger and healthier Americans — to forgo health insurance coverage altogether.

    Over time, that could make the program more expensive for the older, sicker population that remains.

    An analysis conducted last September by the Urban Institute and Commonwealth Fund projected the higher premiums from expiring subsidies would prompt some 4.8 million Americans to drop coverage in 2026.

    But with the window to select and change plans still ongoing until Jan. 15 in most states, the final effect on enrollment is yet to be determined.

    Provost, the single mother, said she is holding out hope that Congress finds a way to revive the subsidies early in the year — but if not, she’ll drop herself off the insurance and keep it only for her four-year-old daughter. She can’t afford to pay for both of their coverage at the current price.

    Last year, after Republicans cut more than $1 trillion in federal health care and food assistance with Trump’s big tax and spending cuts bill, Democrats repeatedly called for the subsidies to be extended. But while some Republicans in power acknowledged the issue needed to be addressed, they refused to put it to a vote until late in the year.

    In December, the Senate rejected two partisan health care bills — a Democratic pitch to extend the subsidies for three more years and a Republican alternative that would instead provide Americans with health savings accounts.

    In the House, four centrist Republicans broke with GOP leadership and joined forces with Democrats to force a vote that could come as soon as January on a three-year extension of the tax credits. But with the Senate already having rejected such a plan, it’s unclear whether it could get enough momentum to pass.

    Meanwhile, Americans whose premiums are skyrocketing say lawmakers don’t understand what it’s really like to struggle to get by as health costs ratchet up with no relief.

    Many say they want the subsidies restored alongside broader reforms to make health care more affordable for all Americans.

    “Both Republicans and Democrats have been saying for years, oh, we need to fix it. Then do it,” said Chad Bruns, a 58-year-old Affordable Care Act enrollee in Wisconsin. “They need to get to the root cause, and no political party ever does that.”

    [ad_2]

    Source link

  • Garlic extract rivals traditional mouthwash for dental hygiene in surprising new review

    [ad_1]

    NEWYou can now listen to Fox News articles!

    A new review from the University of Sharjah suggests that mouthwash made with garlic extract may fight germs as effectively as chlorhexidine, a widely used antiseptic in dental care.

    Chlorhexidine, a common ingredient in mouthwash, is often considered the gold standard for reducing bacteria, but it can come with its own drawbacks. The researchers wanted to see whether garlic, long known for antimicrobial properties, could offer a natural alternative.

    “Chlorhexidine… is associated with side effects and concerns over antimicrobial resistance,” the authors explained in a press release.

    “Garlic, known for natural antimicrobial properties, has emerged as a potential alternative,” the review notes.

    TREATING GUM DISEASE COULD REDUCE RISK OF HEART ATTACKS AND STROKES, STUDY SUGGESTS

    Garlic has natural antimicrobial properties, prompting researchers to examine how it holds up against current mouthwash ingredients. (iStock)

    To explore this, the team searched six scientific databases. They began with 389 studies, but after applying strict criteria, only five clinical trials qualified for inclusion in their reviews.

    These studies compared garlic extract mouthwash with chlorhexidine, and the authors used a standardized framework to structure their questions and measures.

    Man pouring antiseptic mouthwash.

    Chlorhexidine is a common ingredient in antibacterial mouthwash. (iStock)

    The results suggested that higher-concentration garlic mouthwash showed antimicrobial effects similar to chlorhexidine.

    The review explains that the “effectiveness varied based on mouthwash concentration and duration of application, contributing to differences in outcomes.”

    FRUIT-BASED INGREDIENT MAY HELP FIGHT GUM DISEASE NATURALLY, SCIENTISTS DISCOVER

    “Some studies favored chlorhexidine for maintaining higher plaque/salivary pH,” it continued, “while others reported garlic extract to be more effective at certain concentrations.” 

    Overall, the evidence points to garlic having meaningful antimicrobial activity in the mouth.

    “However, garlic mouthwash may cause greater discomfort,” the review notes.

    Closeup smiling woman face hold and smelling head, clove of garlic and greenery on table in kitchen.

    In some of the studies reviewed, garlic extract appeared to be more effective than mouthwash at certain concentrations. (iStock)

    Garlic mouthwash was linked to a burning sensation and an unpleasant flavor, which could affect how willing people are to use it regularly.

    CLICK HERE TO DOWNLOAD THE FOX NEWS APP

    Important to note is that only a few clinical trials were available, despite a large initial pool of research.

    Additionally, the studies that met the criteria used different garlic concentrations, different dosing schedules, and different measures of success, which made direct comparisons difficult.

    “However, garlic mouthwash may cause greater discomfort.”

    CLICK HERE FOR MORE LIFESTYLE STORIES

    Much of the broader research on garlic extract remains laboratory-based rather than clinical, so there is still limited evidence from real-world use in humans.

    CLICK HERE TO SIGN UP FOR OUR LIFESTYLE NEWSLETTER

    Because of these constraints, the authors emphasize that larger, carefully designed clinical trials are needed before garlic extract mouthwash can be considered a reliable alternative to chlorhexidine. 

    Longer study periods would also help determine whether the early signs of effectiveness hold up over time.

    TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

    The findings were published in the Journal of Herbal Medicine. 

    [ad_2]

    Source link

  • New play looking at friendship between AIDS activist Larry Kramer and Anthony Fauci in the works

    [ad_1]

    NEW YORK — A new play exploring the complex relationship between playwright and AIDS activist Larry Kramer and Dr. Anthony Fauci, the longtime top U.S. infectious disease expert, will make its premiere early next year in New York under the direction of Tony Award-winner Daniel Fish.

    “Kramer/Fauci” will star Tony-winner Will Brill from “Stereophonic” and Thomas Jay Ryan, who starred in the film “Henry Fool.” It will play The Jack H. Skirball Center for the Performing Arts between Feb. 11-21, The AP has learned.

    Fish, whose 2019 production of Rodgers and Hammerstein’s “Oklahoma!” won the Tony Award for best musical revival, is using the transcript of a 1993 C-Span face-off between the two men as the text of the play, which included call-ins from across the country.

    “I’m looking at a particular moment in time, at a particular exchange that has resonances into their relationship, has resonances into the politics and culture of the time, and seeing what happens when we do that now. That’s really where I’m coming from,” said Fish.

    Kramer and Fauci went from adversaries to friends as they confronted the AIDS crisis from different sides in the 1980s and ’90s. Kramer, who wrote “The Normal Heart” and founded the AIDS Coalition to Unleash Power, or ACT UP, demanded the government do more and faster for those with symptoms.

    Fauci, the longtime director of the National Institute of Allergy and Infectious Diseases, insisted on a pragmatic approach. He would became a lightning rod again as leader of the national response to the coronavirus pandemic in 2020.

    The exchange in 1993 was heated and illuminating, with Kramer acknowledging their complex relationship: “He is a man, an ordinary man, who is being asked to play God,” Kramer said at the time. “And he is being punished because he cannot be God. And that is a terrible position to be in.”

    After Kramer’s death in 2020, Fish stumbled across the C-Span exchange. “I just thought it was really compelling and it kind of just stayed with me,” he said. “And after a while I thought, ‘I wonder what would happen if we made a performance out of this?’”

    Fish doesn’t want to mount a literal recreation of the exchange, instead reaching for something more theatrical. In 1993, Kramer was beamed in from New York while Fauci was in the C-Span studio in Washington, D.C. For the play, Fish will put the two — plus the moderator — in the same room on stage.

    “There’s a moment where Kramer at one point says, ‘You know, I love Tony Fauci,’ and later on he says, ‘Tony, when you talk like that, I hate you.’ And Fauci says, ‘I know you do, Larry.’”

    [ad_2]

    Source link

  • Stony Brook Medicine launches clinical trials unit in Commack | Long Island Business News

    [ad_1]

    THE BLUEPRINT:

    • 6,000 sq. ft. Unit now open at

    • Features 12 exam rooms, infusion bays, and specialized testing labs

    • Supports trials for all ages

    opened its 6,000-square-foot Clinical Trials Unit at the Advanced Specialty Care at Commack center. Celebrated with a ribbon-cutting on Monday, the unit provides patients with a chance to take part in advanced therapeutic studies and offers physicians and researchers a shared space to conduct clinical trials.

    The space expands Stony Brook’s capacity and research infrastructure to support scientifically rigorous clinical trials that integrate discovery and development to explore new treatments and improve patient outcomes. The facility accommodates trial participants across the lifespan, including children, older adults and individuals with physical disabilities.

    “As we cut the ribbon on this new Clinical Trials Unit here in Commack, we’re celebrating the opening of a new facility, but more importantly, we’re opening doors to discovery and to hope,” Dr. William Wertheim, executive vice president of Stony Brook Medicine, said in a news release about the unit.

    The unit includes 12 examination and consultation rooms, a cardiopulmonary exercise testing facility and a physical performance and gait testing suite. It also features a three-bay infusion area for trials involving chemotherapeutic and intravenous infusions, a procedure room for outpatient trials and a wet lab equipped with a refrigerated centrifuge and a minus-80 F freezer for processing blood and other human samples.

    “This space represents the bridge between groundbreaking research in the laboratory and the patients and families we serve every day, right here in our communities,” Wertheim said.

    The new unit is designed to make advanced clinical trials more accessible to the people served by the system.

    “For decades, Stony Brook Medicine has been known for translating research from bench to bedside,” Wertheim said. “With this new unit, for the first time, we’re extending that promise beyond the hospital, bringing access to advanced clinical trials closer to where people live and work. It’s a tangible example of how we’re strengthening our connection to the community and ensuring that participation in world-class research is not limited by distance or circumstance.”

    Dr. Peter Igarashi, the dean of the Renaissance School of Medicine at Stony Brook University, shared that sentiment.

    “Academic medicine brings added value in the form of expertise of our academic faculty clinicians, as well as access to state-of-the-art technologies and access to clinical trials, and that’s why we have built this facility,” Igarashi said in the news release. “We look forward to the exciting discoveries that will emerge from the research program for years to come.”

    Now fully operational, the unit is staffed with specialists and principal investigators to manage trials from planning to execution. The unit will conduct studies on a range of conditions, including neurological, cardiovascular, pulmonary, kidney, cancer, mental health and infectious diseases.

    “Currently, we have 260 active clinical trials,” Dr. Susan Hedayati, vice dean for research in the Renaissance School of Medicine at Stony Brook University, said in the news release.

    “These trials account for a vast majority of all of the clinical trials within SUNY academic institutions,” Hedayati added. “By building this Commack Clinical Trials Unit, we’re very enthusiastic that we will have the capacity to significantly and substantially increase this number.”


    [ad_2]

    Adina Genn

    Source link

  • Research monkeys got loose after a truck overturned on a highway. Their owner, destination, and exact purpose remain shrouded in mystery | Fortune

    [ad_1]

    The recent escape of several research monkeys after the truck carrying them overturned on a Mississippi interstate is the latest glimpse into the secretive industry of animal research and the processes that allow key details of what happened to be kept from the public.

    Three monkeys have remained on the loose since the crash on Tuesday in a rural area along Interstate 59, spilling wooden crates labeled “live monkeys” into the tall grass near the highway. Since then, searchers in masks, face shields and other protective equipment have scoured nearby fields and woods for the missing primates. Five of the 21 Rhesus macaques on board were killed during the search, according to the local sheriff, but it was unclear how that happened.

    Key details remain shrouded in secrecy

    Mississippi authorities have not disclosed the company involved in transporting the monkeys, where the monkeys were headed or who owns them. While Tulane University in New Orleans has acknowledged that the monkeys had been housed at its National Biomedical Research Center in Covington, Louisiana, it said it doesn’t own them and won’t identify who does.

    An initial report from the sheriff described the monkeys as “aggressive” and carrying diseases such as herpes, adding to the confusion. Tulane later said the monkeys were free of pathogens, but it is still unclear what kind of research the monkeys were used for.

    The questions surrounding the Mississippi crash and the mystery of why the animals were traveling through the South are remarkable, animal advocates say.

    “When a truck carrying 21 monkeys crashes on a public highway, the community has a right to know who owned those animals, where they were being sent, and what diseases they may have been exposed to and harbored simply by being caught up in the primate experimentation industry,” said Lisa Jones-Engel, senior science adviser on primate experimentation with People for the Ethical Treatment of Animals.

    “It is highly unusual — and deeply troubling — that Tulane refuses to identify its partner in this shipment,” Jones-Engel added.

    One thing that is known is that the 2025 Chevrolet Silverado pickup hauling the monkeys was driven by a 54-year-old Cascade, Maryland, man when it ran off the highway into the grassy median area, the Mississippi Highway Patrol said in a statement to The Associated Press. The driver wasn’t hurt, nor was his passenger, a 34-year-old resident of Thurmont, Maryland.

    Confidentiality is built into contracts, blocking information

    Transporting research animals typically requires legally binding contracts that prohibit the parties involved from disclosing information, Tulane University said in a statement to the AP. That’s done for the safety of the animals and to protect proprietary information, the New Orleans-based university said.

    “To the best of Tulane’s knowledge, the 13 recovered animals remain in the possession of their owner and are en route to their original destination,” the statement said.

    The crash has drawn a range of reactions — from conspiracy theories that suggest a government plot to sicken people to serious responses from people who oppose experimenting on animals.

    “How incredibly sad and wrong,” Republican U.S. Rep. Marjorie Taylor Greene said of the crash.

    “I’ve never met a taxpayer that wants their hard-earned dollars paying for animal abuse nor who supports it,” the Georgia congresswoman said in a post on the social platform X. “This needs to end!”

    Tulane center has ties to more than 155 institutions worldwide

    Tulane’s Covington center has received $35 million annually in National Institutes of Health support, and its partners include nearly 500 investigators from more than 155 institutions globally, the school said in an Oct. 9 news release. The center has been funded by NIH since 1964, and federal grants have been a significant source of income for the institution, it said.

    In July, some of the research center’s 350 employees held a ribbon-cutting ceremony to mark the opening of a new 10,000-square-foot office building and a new laboratory at the facility. This fall, the facility’s name was changed from the Tulane National Primate Research Center to the Tulane National Biomedical Research Center to reflect its broader mission, university officials announced.

    Research monkeys have escaped before in South Carolina, Pennsylvania

    The Mississippi crash is one of at least three major monkey escapes in the U.S. over the past four years.

    Last November, 43 Rhesus macaques escaped from a South Carolina compound that breeds them for medical research after an enclosure wasn’t fully locked. Employees from the Alpha Genesis facility in Yemassee, South Carolina, set up traps to capture them. However, some spent two months that winter living in the woods and weathering a rare snowstorm. By late January, the last four escapees were recaptured after being lured back into captivity by peanut butter and jelly sandwiches.

    In January 2022, several cynomolgus macaque monkeys escaped when a truck towing a trailer of about 100 of the animals collided with a dump truck on a Pennsylvania highway, authorities said. The monkeys were headed to a quarantine facility in an undisclosed location after arriving at John F. Kennedy International Airport in New York on a flight from Mauritius, an Indian Ocean island nation, authorities said. A spokesperson for the Centers for Disease Control and Prevention said all of the animals were accounted for within about a day, though three were euthanized for undisclosed reasons.

    [ad_2]

    Jeff Martin, The Associated Press

    Source link

  • How a tiny retinal implant is helping people regain their sight

    [ad_1]

    NEWYou can now listen to Fox News articles!

    A new study in The New England Journal of Medicine revealed that the PRIMA brain computer interface (BCI) retinal implant helped people with advanced age-related macular degeneration regain some central vision. The device uses a tiny 2 millimeter by 2 millimeter photovoltaic implant that is only 30 micrometers thick, and thinner than a strand of hair. It sits beneath the retina and works with a special pair of smart glasses. The glasses capture images and send them as near-infrared light to the implant. The implant converts that light into small electrical signals that stimulate the optic nerve. This process mimics how healthy retinal cells normally send visual information to the brain.

    The study followed 38 participants, 32 of whom completed one year of follow-up. Twenty-six patients experienced measurable improvement in vision, which equals about 80% of the group. Many participants could read letters, numbers and even full pages of text again. Although the restored vision is black and white and slightly blurry, the results are remarkable for people who once believed they would never see clearly again.

    WORLD’S THINNEST AI GLASSES FEATURE BUILT-IN AI ASSISTANT

    Sign up for my FREE CyberGuy Report
    Get my best tech tips, urgent security alerts, and exclusive deals delivered straight to your inbox. Plus, you’ll get instant access to my Ultimate Scam Survival Guide — free when you join my CYBERGUY.COM newsletter.

    Why this matters for AMD treatment

    Age-related macular degeneration, often called AMD, is one of the leading causes of irreversible blindness in older adults. Until now, available treatments could only slow down vision loss. None of them could restore what had already been lost.

    The PRIMA implant works with smart glasses to bring central vision back to life. (PRIMA by Science)

    The PRIMA implant takes a different approach. It directly replaces the missing function of the retina by turning light into electrical signals. Patients can still use their natural peripheral vision while the implant restores some central vision. This combination creates a more complete visual experience.

    The trial showed that the surgery is generally safe. Most side effects occurred within the first two months and resolved soon after. Importantly, the implant did not reduce the patients’ remaining natural peripheral vision. Researchers call this a major step toward restoring sight rather than only slowing its decline.

    The PRIMA implant was developed by Science Corporation, a brain-computer interface company founded by Max Hodak, who previously cofounded Neuralink. Science Corporation acquired the PRIMA technology from the French firm Pixium Vision, continuing its development toward clinical use.

    EYE DROPS MAY REPLACE READING GLASSES FOR THOSE STRUGGLING WITH AGE-RELATED VISION LOSS

    A visual implant is seen next to a key.

    The tiny chip sits under the retina and turns light into visual signals. (PRIMA by Science)

    What this means for you

    If you or someone you love lives with late-stage AMD, this breakthrough may offer real hope. For the first time, there is a device that can restore some sight instead of only preserving what remains. You may want to talk with your ophthalmologist about upcoming trials or future approval of the PRIMA system in your area. The company behind the technology has already applied for European approval, and a process with the U.S. Food and Drug Administration is underway.

    Regaining even partial central vision can make a big difference. Reading text, recognizing faces or simply moving independently becomes possible again. This progress also shows how fast medical innovation is moving. Patients who were once told that nothing could help may soon have a chance to see again.

    It is also a reminder to stay informed. Treatments that were once experimental are becoming available sooner than expected. Discussing new technologies with your doctor helps you understand timing, eligibility and what kind of results you can realistically expect.

    Woman gets eye exam at doctor's office

    This breakthrough offers new hope for people living with advanced macular degeneration. (PeopleImages/Getty Images)

    Take my quiz: How safe is your online security?

    Think your devices and data are truly protected? Take this quick quiz to see where your digital habits stand. From passwords to Wi-Fi settings, you’ll get a personalized breakdown of what you’re doing right and what needs improvement. Take my Quiz here: CyberGuy.com.

    CLICK HERE TO DOWNLOAD THE FOX NEWS APP

    Kurt’s key takeaways

    The PRIMA retinal implant represents a shift in how scientists and doctors think about blindness caused by AMD. For decades, the focus was on slowing down the disease. Now, researchers are proving that restoration is possible. While this generation of the implant provides limited black and white vision, it gives real, functional sight to people who had none. That alone changes lives. More work remains to improve image clarity, color perception and comfort. Still, this is only the beginning. Future versions of the device and smart glasses may make vision restoration even more effective and accessible.

    If you could regain even part of your sight through new technology, would you take the opportunity and experience the world in a whole new way? Let us know by writing to us at CyberGuy.com.

    Sign up for my FREE CyberGuy Report
    Get my best tech tips, urgent security alerts and exclusive deals delivered straight to your inbox. Plus, you’ll get instant access to my Ultimate Scam Survival Guide — free when you join my CYBERGUY.COM newsletter.

    Copyright 2025 CyberGuy.com. All rights reserved.  

    [ad_2]

    Source link

  • Doctors on key US health task force accused of prioritizing DEI over evidence-based medicine

    [ad_1]

    NEWYou can now listen to Fox News articles!

    An “independent” advisory panel of non-federal experts determining which preventative healthcare services insurers must cover is accused of being staffed with doctors who have shown a propensity to prioritize “woke” left-wing diversity, equity and inclusion ideals in their work, as opposed to evidence-based science.

    The U.S. Preventative Services Task Force (USPSTF), an all-volunteer panel of doctors who serve four-year terms appointed by the Secretary of Health, is made up of experts in preventative medicine, which includes services like screening tests, immunizations, behavioral counseling, and medications that can prevent the development or worsening of health conditions. One of the task force’s primary functions is to weigh the efficacy and cost-benefit of such preventative care services, recommendations for which are then used to shape what preventative care services insurance providers must cover.

    The task force’s ability to make these healthcare recommendations, coupled with what appears to be a membership largely made up of left-wing, DEI proponents, has raised concerns about how the task force could be impacting healthcare. 

    The Wall Street Journal reported in July that sources with knowledge of Health Secretary Robert F. Kennedy Jr.’s thinking said he was planning to dismiss all 16 members of the USPSTF for being too “woke.” 

    NEW MEDICAL POLICY CENTER COMBATS WOKENESS IN MEDICINE, LAUNCHING LANDMARK RANKING OF TOP SCHOOLS

    RFK Jr. speaks at the 2025 Rx and Illicit Drug Summit at Gaylord Opryland Resort and Convention Center in Nashville, Tenn., Thursday, April 24, 2025. (© Nicole Hester / The Tennessean / USA TODAY NETWORK)

    “HHS has been made aware of the ideological issues with members of the USPSTF raised by letters from Senate Republicans, members of the GOP Doctors Caucus, and a large group of physicians including Associations of American Physicians and Surgeons, America’s Frontline Doctors, and the Pennsylvania Direct Primary Care Association. HHS is troubled by these allegations and is investigating further,” Emily Hilliard, a Health and Human Services Department spokesperson told Fox News Digital when asked about Kennedy’s plans for the future of the current USPSTF.

    Meanwhile, others, including the GOP Doctors Caucus and major physician groups including the Association of American Physicians and Surgeons, have also raised alarm bells about potential left-wing bias at the USPSTF. One group that has also raised alarm bells about the USPSTF is the conservative watchdog group known as the American Accountability Foundation (AAF), which just released a new report claiming the USPSTF “has been thoroughly hijacked by left-wing partisans for the purpose of weaponizing science to spread leftist ideology.”

    The AAF report points to Dr. Michael Silverstein, the task force’s current chairman, who, in 2023, said that USPSTF is “dedicated to … addressing critical issues of health equity” after he was re-appointed to the task force’s leadership team under the Biden administration. As Vice Chair of the task force in 2023, Silverstein co-authored an annual report to Congress highlighting a new partnership with the Gay and Lesbian Medical Association (GLMA) aimed at helping the task force be more “inclusive.”

    The partnership, according to the report to Congress, was meant to help develop “new recommendations on screening for anxiety disorders, and other conditions that affect LGBTQ+ communities to enhance the health, wellness, and quality of life of their patients.”

    Other recommendations from the USPSTF that have come down in the last several years include a 2022 recommendation denoting the need for physicians to consider race when screening for anxiety in children and adolescents. A more recent recommendation, published in April, said that doctors should pay special attention to breastfeeding in black mothers due to the “lasting psychological impact and stigma of enslaved Black women being forced to act as wet nurses.” 

    I’M A GENDER DETRANSITIONER. I TOLD THE FTC HOW DOCTORS ABUSED THEIR POWER OVER ME     

    Denver-Health

    Denver, CO – APRIL 25 : Medical doctor Alia Broman, right, examines a 6 years old patient at Denver Health in Denver, Colorado on Thursday, April 25, 2024.  (Hyoung Chang/The Denver Post))

    Meanwhile, a 2021 report from the USPSTF, on addressing sex and gender when making preventative healthcare recommendations, included an analysis of how gender-specific terminology, as opposed to “gender-neutral” terminology, could play a role in addressing the needs of “diverse populations.” Think “pregnant people” versus “pregnant mother,” a switch that eventually became part of the task force’s official guidelines. 

    “To advance its methods, the USPSTF reviewed its past recommendations that included the use of sex and gender terms, reviewed the approaches of other guideline-making bodies, and pilot tested strategies to address sex and gender diversity,” the report states. “Based on the findings, the USPSTF intends to use an inclusive approach to identify issues related to sex and gender at the start of the guideline development process; assess the applicability, variability, and quality of evidence as a function of sex and gender; ensure clarity in the use of language regarding sex and gender; and identify evidence gaps related to sex and gender.”

    Another major achievement towards the task force’s mission to advance “health equity” was the release of a 2024 “Health Equity Framework” aimed at embedding gender theory and other left-wing ideologies into its operations. 

    HOW UNIVERSITY INDOCTRINATION TURNED DEADLY, AND WHY ONE SCHOLAR SAYS IT’S ONLY GETTING WORSE  

    In addition to the work the task force has done, its members also have an extensive history of publishing research that focuses on “health equity” and other DEI components, such as how race impacts certain health outcomes, or how to address sex and gender when making recommendations for clinical preventative services.

    “National Institutes of Health Pathways to Prevention Workshop: Achieving Health Equity in Preventive Services,” is the title of a scientific research report co-authored by task force rank-and-file member, Dr. Sandra Millon Underwood. “Further Incorporating Diversity, Equity, and Inclusion Into Medical Education Research,” and “Health Equity Starts with Us: Recommendations from the Indiana Clinical and Translational Sciences Institute Racial Justice and Health Equity Task Force,” were also reports co-authored by members of the USPSTF.

    “Antiracist initiatives, such as incorporating community-support persons (e.g., lay doulas) into maternity care for Black people, can reduce disparities in outcomes by addressing both interpersonal racism and the lack of workforce diversity caused by structural racism,” stated a May 2024 research paper co-authored by USPSTF rank-and-file member Dr. Alicia Fernandez.

    Doctor seen next to Diversity, Equity and Inclusion image

    The U.S. Preventative Services Task Force (USPSTF) has been accused of being infiltrated by “woke” leftists, with sources familiar with Heath Secretary Robert F. Kennedy saying he has plans to fire all 16 of them.  (iStock; Getty Images)

    Members of the supposedly “independent” USPSTF have also used their positions of expertise to fight Trump administration priorities as well, such as those around abortion and research funding reforms. 

    For example, Dr. David Chelmow, another task force member, has appeared in several physician-backed American Civil Liberties Union memos about efforts opposing the Trump administration, including one challenging Trump’s efforts to implement greater protections around the mail-order abortion drug called mifepristone, which many pro-life OBGYN’s have warned is dangerous if not dispensed in-person. In March, Dr. Carlos Roberto Jaen, another task force member, signed a letter alongside 1,900 others accusing the Trump administration of weakening US research capacity and endangering Americans.

    WHAT’S REALLY IN YOUR FOOD? NEW CAMPAIGN PUSHES FOR NATIONAL INGREDIENT TRANSPARENCY 

    When making recommendations for preventative care services, the USPSTF assigns a letter grade, A, B, C, D, or I. 

    Any service given an “A” or “B” grade, is required to be covered by private insurers under a mandate in the Affordable Care Act (ACA). These grades are also tied to coverage requirements for public insurers, like Medicare and Medicaid. 

    In 2019, the task force gave the precautionary anti-HIV drug Preexposure Prophylaxis (PrEP) an “A” grade, guidelines for which were later clarified in 2023. The task force’s current Vice Chair, Dr. John Wong, also co-authored a 2017 paper on how scaling-up the use of PrEP can help reduce the prevalence of HIV among gay men. But, according to AAF, the active promotion of PrEP creates an atmosphere of dangerous sexual activity that risks public health dangers due to what the foundation says is promotion of risky sexual behaviors. Additionally, at least one Christian-owned business has argued that forcing insurance providers to cover medication that promotes risky sexual behaviors violates their rights.

    Earlier this summer, the Supreme Court weighed in on whether the USPSTF’s authority to compel coverage of preventative healthcare it gives either an “A” or “B” grade was unconstitutional. The group that brought the case, Braidwood Management Inc., initially objected on religious grounds to the ACA requirement that insurance providers cover certain HIV-prevention medications for which the task force has issued an “A” recommendation, specifically PrEP. However, the case ultimately morphed into a question over the legitimacy of USPSTF’s recommendation authority, and whether the circumvention of Senate approval for its members was allowed by the Constitutions Article II clause on advise and consent.

    Supreme Court

    The facade of the Supreme Court building at dusk is shown in this photo. (Drew Angerer/Getty Images)

    CLICK HERE TO GET THE FOX NEWS APP 

    Both the Biden and Trump administrations have taken up the argument that the Health Secretary alone has ultimate control over whether to appoint or fire USPSTF members. The Trump administration also argued in its briefs to the High Court that the Secretary had the authority to block, or rescind, task force recommendations as well, according to SCOUTS Blog.   

    Ultimately, the Supreme Court voted 6-3, in favor of the federal government’s argument that the appointment process for the USPSTF, and therefore its legitimacy, did not violate the Constitution.

    Shortly after the Supreme Court’s decision in the Braidwood case, Health Secretary Kennedy reportedly postponed a long-scheduled task force meeting of the USPSTF, which was the same move he made before firing every member of the Advisory Committee on Immunization Practices (ACIP), the main federal entity that helps craft federal vaccine policy. Kennedy has long been a critic of conventional vaccination policies and practices.    

    The Wall Street Journal reported in July, not long after the Supreme Court’s decision in the Braidwood case, that sources familiar with Kennedy’s thinking said he was planning to dismiss all 16 members of the USPSTF for being too “woke.”

    [ad_2]

    Source link

  • New vitamin compound shows promise for reversing Alzheimer’s damage to the brain

    [ad_1]

    NEWYou can now listen to Fox News articles!

    An enhanced version of vitamin K could help reverse brain damage from Alzheimer’s disease, a study has found.

    Alzheimer’s and many other neurodegenerative diseases are marked by a loss of brain neurons. While most medications treat only the symptoms, researchers from the Department of Bioscience and Engineering at Shibaura Institute of Technology in Japan set out to determine whether a new approach could replace the lost cells.

    Vitamin K is an essential nutrient that aids with blood clotting, bone health and other important functions in the body, according to the National Institutes of Health. 

    SIMPLE DIET CHANGE MAY SUPPORT GUT HEALING FOR CANCER SURVIVORS, RESEARCHERS SAY

    While it has been shown to support brain protection and neuron creation, the natural forms of vitamin K — including menaquinone-4 (MK-4) — might not be powerful enough to effectively treat neurodegenerative diseases, experts say.

    An enhanced version of vitamin K could help reverse brain damage from Alzheimer’s disease, a study has found. (iStock)

    To boost its potency, researchers from the Department of Bioscience and Engineering at Shibaura Institute of Technology in Japan developed new, stronger forms of the vitamin.

    They did this by creating 12 new versions of vitamin K and combining it with retinoic acid, an active metabolite of vitamin A that helps brain cells grow and develop.

    CLICK HERE TO GET THE FOX NEWS APP

    In lab tests, the new lab-made versions of vitamin K were about three times more effective than natural vitamin K at helping immature brain cells develop into neurons, according to study co-lead Associate Professor Yoshihisa Hirota.

    Senior woman vitamins

    Vitamin K is an essential nutrient that aids with blood clotting, bone health and other important functions in the body. (iStock)

    The new vitamin K compound was also shown to successfully cross the blood-brain barrier in animal tests. 

    Another important benefit, the researchers noted, is that the new molecules retained the same benefits of vitamin K and vitamin A while showing stronger brain-cell activity.

    CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

    The findings were published in the journal ACS Chemical Neuroscience.

    Doctor analyzing brain scan

    The new vitamin K compound was also shown to successfully cross the blood-brain barrier in animal tests.  (iStock)

    “Since neuronal loss is a hallmark of neurodegenerative diseases such as Alzheimer’s disease, these analogues may serve as regenerative agents that help replenish lost neurons and restore brain function,” Hirota said in a press release.

    TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

    Looking ahead, the research team plans to test the new compounds in animal and human studies, in hopes that this could lead to a new approach for slowing or repairing brain degeneration for patients with neurodegenerative diseases. 

    CLICK HERE FOR MORE HEALTH STORIES

    “A vitamin K-derived drug that slows the progression of Alzheimer’s disease or improves its symptoms could not only improve the quality of life for patients and their families, but also significantly reduce the growing societal burden of healthcare expenditures and long-term caregiving,” Hirota added.

    [ad_2]

    Source link

  • UC Santa Barbara develops new soft robotic system for emergency intubation procedures

    [ad_1]

    NEWYou can now listen to Fox News articles!

    When someone stops breathing, the clock starts ticking. First responders often need to get air into the lungs fast, and one of the most reliable ways is to slide a tube into the windpipe. This process, called intubation, keeps the airway open so that oxygen can flow again.

    Here’s the catch: intubation is incredibly hard. Even trained doctors can struggle, and every extra second puts the patient at greater risk. Now, researchers at UC Santa Barbara have designed a soft robotic device that could change how first responders handle these emergencies. It helps guide the breathing tube into place quickly, safely, and with far less training than traditional methods.

    Sign up for my FREE CyberGuy Report
    Get my best tech tips, urgent security alerts and exclusive deals delivered straight to your inbox. Plus, you’ll get instant access to my Ultimate Scam Survival Guide – free when you join my CYBERGUY.COM newsletter.

    Why breathing tubes are so tough to place

    Our bodies are built to keep food and foreign objects out of the lungs. A small flap called the epiglottis blocks the windpipe during swallowing, and the path into the trachea is narrow and curved. To get around these obstacles, current tools are rigid. Medics have to lift the epiglottis with a metal scope and carefully angle the tube forward. If it slips into the esophagus instead, oxygen goes to the stomach instead of the lungs. “Traditional tools must be stiff so you can push them, and they only turn by pressing on sensitive tissue,” explained Elliot Hawkes, professor of mechanical engineering at UCSB.

    DANGEROUS HEART CONDITIONS DETECTED IN SECONDS WITH AI STETHOSCOPE

    Even trained doctors can struggle with intubation. (Universal Images Group/Getty Images)

    How the soft robot works

    The new system, called the soft robotic intubation system (SRIS), takes a gentler approach. First, a curved guide sits at the back of the throat. Then a soft inflatable tube slowly unrolls from the inside out as it advances. Instead of being forced in, it naturally follows the right path into the windpipe. This reduces friction, lowers the risk of injury and adapts to different body shapes automatically. “This growing paradigm naturally accounts for minor variations in anatomy,” said lead author David Haggerty, a recent UCSB Ph.D. graduate.

    What the tests show

    The results are eye-opening:

    • Experts had a 100% success rate.
    • Paramedics and EMTs reached a 96% success rate with just five minutes of training.
    • Non-experts placed the tube in an average of 21 seconds, less than half the time needed with advanced video laryngoscopes.

    Why this device could save more lives

    Millions of emergency intubations happen in the U.S. each year. Many take place in chaotic, low-light or stressful situations where current tools don’t always work. A device that makes the process easier could be a lifesaver for:

    • Paramedics at accident scenes
    • Military medics in combat zones
    • Doctors in hospitals with limited equipment

    AI VIDEO TECH FAST-TRACKS HUMANOID ROBOT TRAINING

    A row of ambulances parked at a hospital emergency bay, ready for dispatch.

    In trials, both experts and non-experts achieved faster and more successful intubations using the new airway management system — advancing emergency response efficiency. (Kurt Knutsson)

    The UCSB team is now preparing for clinical trials and FDA approval.

    HOW MICRO-ROBOTS MAY SOON TREAT YOUR SINUS INFECTIONS

    What this means for you

    If this device lives up to its early promise, it could mean that more patients survive emergencies where breathing stops. For families, it means a higher chance that first responders can keep loved ones alive until they reach the hospital. For medics, it offers a safer, faster tool when seconds truly matter.

    Take my quiz: How safe is your online security?

    Think your devices and data are truly protected? Take this quick quiz to see where your digital habits stand. From passwords to Wi-Fi settings, you’ll get a personalized breakdown of what you’re doing right and what needs improvement. Take my Quiz here: Cyberguy.com.

    Kurt’s key takeaways

    Breathing is life, yet securing an airway is one of the toughest jobs in emergency care. This soft robotic system may help turn a high-risk procedure into something more predictable and safe. While more testing is still ahead, the early data shows how robotics could make a lifesaving difference for patients everywhere.

    Medical professionals practice artificial respiration on a training mannequin in a hospital setting.

    Medical staff participate in hands-on training to practice emergency response and resuscitation techniques using a lifelike simulation mannequin. (Universal Images Group/Getty Images)

    CLICK HERE TO GET THE FOX NEWS APP

    Would you feel more confident knowing first responders in your community had access to this kind of lifesaving robot? Let us know by writing to us at Cyberguy.com.

    Sign up for my FREE CyberGuy Report
    Get my best tech tips, urgent security alerts and exclusive deals delivered straight to your inbox. Plus, you’ll get instant access to my Ultimate Scam Survival Guide – free when you join my CYBERGUY.COM newsletter.

    Copyright 2025 CyberGuy.com. All rights reserved.  

    [ad_2]

    Source link

  • Trio Wins Nobel Prize in Medicine for Discoveries on Immune System

    [ad_1]

    Immunologists Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi were awarded the Nobel Prize in Physiology or Medicine for discoveries that spurred the development of new treatments for cancer and autoimmune diseases and laid the foundation for a new field of research.

    The trio identified a core feature of how the immune system functions and keeps itself in-check: regulatory T-cells. They prevent other immune cells from attacking our own bodies and developing autoimmune conditions including Type 1 diabetes and rheumatoid arthritis. Based on this fundamental knowledge, clinical trials are ongoing to test therapies for autoimmune diseases, cancer and following organ transplantation.

    Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

    [ad_2]

    Brianna Abbott

    Source link

  • Prostate cancer patients see longer survival with new combination drug

    [ad_1]

    NEWYou can now listen to Fox News articles!

    A new treatment strategy tested by UCLA researchers could offer new hope for men whose prostate cancer has returned after initial treatment.

    This approach could also help delay the need for hormone therapy, which can have burdensome side effects.

    The findings, which were presented at the annual American Society for Radiation Oncology (ASTRO) meeting this week, showed that combining a targeted radioactive drug with standard radiation therapy more than doubled the amount of time patients remained free of disease progression.

    NEW BREAST CANCER DRUG WINS FDA APPROVAL AFTER SLASHING PROGRESSION RISK BY NEARLY 40%

    The study focused on men with a form of cancer recurrence where the disease had returned in only a few isolated spots. Traditionally, this has been treated with a type of focused radiation called stereotactic body radiation therapy, a highly precise type of radiation therapy used to treat tumors in the body.

    The UCLA-led team wanted to determine whether adding a PSMA-targeted radioligand therapy, a radioactive drug that zeroes in on cancer cells, would be more effective, according to a press release.

    The study focused on men with a form of cancer recurrence where the disease had returned in only a few isolated spots.  (iStock)

    The researchers enrolled 92 men with recurring prostate cancer into the trial. Half received radiation alone, while the other half received the new drug plus radiation.

    The men who received both treatments stayed cancer-free for a median of nearly 18 months, compared to about seven months for those who got radiation alone.

    CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

    “This is the first randomized trial to show that PSMA-targeting radioligand can significantly delay progression when added to metastasis-directed radiation,” Dr. Amar Kishan, executive vice chair of radiation oncology at UCLA and lead author of the study, told Fox News Digital.

    Doctor talking to a patient in a consultation at the office

    One of the biggest benefits is the potential for patients to delay starting hormone therapy, according to the lead researcher. (iStock)

    Kishan called the work “a great example of true collaboration between radiation oncology and nuclear medicine.”

    CLICK HERE TO GET THE FOX NEWS APP

    One of the biggest benefits is the potential for patients to delay starting hormone therapy, according to Kishan. While this is a common next step, it often brings side effects like fatigue, bone loss and mood changes.

    “It gives patients more time before needing hormonal therapy,” Kishan said. “Avoiding or delaying hormonal therapy consistently benefits quality of life.”

    Man waiting for MRI scan

    “This is the first randomized trial to show that PSMA-targeting radioligand can significantly delay progression when added to metastasis-directed radiation,” said the lead researcher. (iStock)

    Despite the improvements, the cancer eventually came back for many of the patients. 

    “There is always room for improvement,” Kishan noted. “There were still progression events … so there may be ways to optimize the treatment further.”

    MORE IN HEALTH NEWS

    The new drug, called 177Lu-PNT2002, is not yet FDA-approved for use at this stage of disease.

    For now, Kishan recommends that men who are experiencing a spread of their prostate cancer to areas outside the prostate should “seek a consultation with a radiation oncologist to explore options.”

    [ad_2]

    Source link

  • Steep Trump cuts haven’t effectively ended medical research

    [ad_1]

    President Donald Trump has made historically large cuts to medical research, some of them aimed at ending what he refers to as diversity, equity and inclusion in federally funded studies. His administration is proposing more: Overall funding for the National Institutes of Health would return to its 2007 level if Trump’s budget proposal were to be enacted. A recent New York Times story highlighted Trump’s billions in proposed National Cancer Institute cuts and carried the headline, “Trump Is Shutting Down the War on Cancer.”

    In the midst of a fight with Republicans over spending and a possible government shutdown, House Minority Leader Hakeem Jeffries, D-N.Y., criticized the Trump administration’s efforts to cut back medical research funding during a Q&A with reporters.

    “Republicans have effectively ended medical research in the United States of America,” Jeffries said Sept. 24.

    Has the Trump administration really ended medical research? While a substantial amount has disappeared, and more could be on the way out if Trump gets his way, Jeffries exaggerated the outlook, even allowing for his “effectively” caveat. Billions of dollars would remain even in the most austere scenario, and there’s uncertainty about whether his most severe proposed cuts will receive congressional approval. 

    Even after proposing substantial cuts to the budget of the National Institutes of Health — the main engine funding U.S. medical research — Trump’s proposal would give the institutes $27 billion for fiscal year 2026. 

    Sign up for PolitiFact texts

    And Trump’s proposal is not final; Congress could increase that amount. Some experts call that scenario likely.

    “The appropriations language making its way through Congress is much less draconian, so it may be too early to know where all this is going to land,” said Richard Frank, a senior fellow at the Brookings Institution, a Washington, D.C., think tank.

    Jeffries’ office did not provide additional evidence for his statement.

    What cuts has Trump made so far?

    Trump’s cuts so far take several forms, said Joshua Weitz, a University of Maryland biology professor who co-founded the Science and Community Impacts Mapping Project, which is tracking the impacts of federal funding cuts nationally. Some of these cutbacks are being challenged in court.

    • Weeks after Trump’s inauguration, the National Institutes of Health announced major cuts to “indirect costs” —  funds that pay for facilities, safety and grant administration. It capped indirect costs for labs working on NIH grants at 15%. Previously, the average rate was about 28%, and sometimes above 60%.

    • The White House has terminated thousands of research grants worth approximately $5 billion. Some of these were canceled for being related to diversity, equity and inclusion, a top target of the administration, such as a $3.8 million Asian Bipolar Genetics Network study to a $1.05 million Alzheimer’s and dementia study focusing on Black Americans. Others were related to administration efforts to punish elite universities for allegedly allowing antisemitism on campus, leading to hiring freezes and holds on clinical trials, Harvard University economist David Cutler and Harvard economist Edward Glaeser co-wrote a recent paper in JAMA Health Forum. “A fraction of these grants have been reinstated, but science does not turn on and off like a spigot,” Weitz said. “Interrupting research leads to wasted studies, risks projects, and is already causing job loss.”

    • Through early April, the NIH ousted 1,200 employees, and granted an unknown number of retirements and resignations. At the Food and Drug Administration, which approves drugs, thousands of jobs have been eliminated.

    • The president’s budget proposal would cut NIH funding from about $45 billion to about $27 billion. That’s a roughly 39% cut for a budget item that in recent decades has almost always increased from year to year. The proposed budget would eliminate the National Institutes for Nursing Research, the National Center for Complementary and Integrative Health, the Fogarty International Center, and the National Institute on Minority Health and Health Disparities.

    The consequences of these cuts could be significant. 

    “Our research shows that while cutting NIH funding may appear to save money in the short term, it can trigger a chain of effects that increase long-term health care costs and slow the development of new treatments and public health solutions over time,” Harvard University health policy and data specialists Mohammad S. Jalali and Zeynep Hasgül wrote for The Conversation. 

    Between 2010 and 2019, all but two of the 356 drugs approved by the Food and Drug Administration received some NIH funding, one study found. So any cuts could reduce the number of drugs in the pipeline, experts say.

    Once all the follow-on impacts reverberate throughout the U.S. economy and health care system, the cuts could prompt an “$8 trillion health care catastrophe,” Cutler and Glaeser wrote. They estimated that the losses from reduced health would be 16 times greater than the proposed budgetary savings.

    Despite the cuts, medical research is here to stay

    The cuts are extensive but do not end U.S. medical research.

    Trump’s slashed NIH budget would still spend more than $27 billion in fiscal year 2026. 

    “Novel biomedical discoveries that enhance health and lengthen life are more vital than ever to our country’s future,” the agency said in its budget proposal. “NIH research is critical to protect national security and sustain the United States’ scientific competitiveness, globally.”

    The president’s proposal highlighted initiatives on nutrition, obesity, heart disease, diabetes, asthma, autism, and cancer, all priorities of Health and Human Services Secretary Robert F. Kennedy Jr.

    The FDA would receive a modest budgetary bump under Trump’s budget proposal, to almost $6.8 billion. 

    Despite the Republican majority’s generally close alignment with Trump’s policy agenda, Congress is on record rejecting his proposed medical research cuts, at least in the preliminary stage. 

    The Senate and House appropriations committees have voted for modest increases in NIH’s budget rather than Trump’s large cuts. They also voted to fund CDC and FDA at higher levels than Trump set out in his budget proposal.

    These increases are not guaranteed; they will have to go through negotiations between lawmakers and the president before final passage. 

    “Congress is likely to approve much smaller cuts than the Administration had proposed,” said Sherry Glied, a professor at New York University’s Robert F. Wagner Graduate School of Public Service.

    Our ruling

    Jeffries said, “Republicans have effectively ended medical research in the United States of America.”

    Trump has proposed severe cuts to medical research at the National Institutes of Health and other agencies, including caps on indirect costs for grantees’ labs, terminated grant funding and staff reductions. But this is not tantamount to effectively ending U.S. medical research.

    Even if Trump gets his way on a 39% cut to NIH’s budget in 2026, the institutes would still have more than $27 billion to spend in fiscal year 2026.

    Trump’s fellow Republicans in Congress may not go along with cuts on the scale the president proposed. Appropriations committees in both the Senate and the House have already rejected Trump’s steep cuts on medical research.

    Trump’s medical research cuts are real and sweeping, but they have not “effectively ended medical research.” We rate the statement Mostly False.

    [ad_2]

    Source link

  • California moves to distance itself from CDC on vaccines, considers creating its own agency

    [ad_1]

    UPDATES AS THEY COME IN. OTHER NEWS, RIGHT NOW, HEALTH OFFICIALS ARE FOCUSING ON VACCINE DEADLINES. THIS WEEK, A CDC COMMITTEE WILL CONSIDER POSSIBLE CHANGES TO RECOMMENDATIONS TOMORROW. AND NOW THE STATE OF CALIFORNIA IS CONSIDERING DISTANCING ITSELF FROM THE FEDERAL GOVERNMENT’S GUIDELINES. THE POTENTIAL CHANGE IN GUIDANCE COMES AS THE RECENTLY FIRED CDC DIRECTOR WARNS THOSE CHANGES MAY NOT BE BASED ON SCIENCE. WE HAVE TEAM COVERAGE FOR YOU OF WHAT YOU NEED TO KNOW. ASHLEY ZAVALA HAS THE CHANGE IN STATE VACCINATION GUIDELINES, BUT WE START WITH JACKIE DEFUSCO LIVE ON CAPITOL HILL FOR US WITH A MESSAGE FROM THE FORMER CDC DIRECTOR. YEAH. HEY THERE, ANDREA CURTIS ON CAPITOL HILL TODAY, THE FORMER CDC DIRECTOR, SUSAN MONAREZ, CLAIMED THAT SHE WAS FIRED IN PART FOR ESSENTIALLY REFUSING TO PRE-APPROVE VACCINE RECOMMENDATIONS WITHOUT SEEING THE SCIENTIFIC EVIDENCE FIRST. SHE TOLD SENATORS THAT SHE IS NERVOUS ABOUT WHAT’S TO COME. TAKE A LISTEN. BASED ON WHAT I OBSERVED DURING MY TENURE, THERE IS A REAL RISK THAT RECOMMENDATIONS COULD BE MADE RESTRICTING ACCESS TO VACCINES FOR CHILDREN AND OTHERS IN NEED WITHOUT RIGOROUS SCIENTIFIC REVIEW, WITH NO PERMANENT CDC DIRECTOR IN PLACE, THOSE RECOMMENDATIONS COULD BE ADOPTED. HEALTH SECRETARY ROBERT F KENNEDY JR HAS DENIED THAT HE ORDERED MONAREZ TO RUBBER STAMP VACCINE RECOMMENDATIONS. BUT THE DISPUTE COMES AS THE CDC’S INFLUENTIAL ADVISORY PANEL, WHOSE MEMBERS WERE RECENTLY REPLACED BY KENNEDY, IS SET TO CONVENE TOMORROW TO CONSIDER POSSIBLE CHANGES TO GUIDANCE ON COVID 19, CHICKENPOX AND HEPATITIS B SHOTS. TELLING LAWMAKERS THAT SHE HAS NOT SEEN ANY DATA AT THIS POINT TO SUPPORT CHANGING ELIGIBILITY CRITERIA. FORMER CDC CHIEF MEDICAL OFFICER DEBORAH OURY, WHO RECENTLY RESIGNED, ALSO TESTIFIED TODAY. AND SHE SAID THAT ONE OF KENNEDY’S POLITICAL ADVISERS TOLD HER NOT TO INCLUDE INFORMATION THAT COULD SUPPORT MAINTAINING HEPATITIS B SHOTS FOR NEWBORNS TO PREVENT THE DEADLY DISEASE FROM SPREADING FROM THE MOTHER. YOU’RE SUGGESTING THAT THEY WANTED TO MOVE AWAY FROM THE BIRTH DOSE, BUT THEY WERE AFRAID THAT YOUR DATA WOULD SAY THAT THEY SHOULD RETAIN IT. IT. WHAT DO WE DO NOW? IT’S STILL UNCLEAR AT THIS POINT HOW EXACTLY THE ADVISORY PANEL WILL VOTE LATER THIS WEEK, BUT SOME MEMBERS IN THE PAST HAVE QUESTIONED THE NECESSITY OF THE HEPATITIS B SHOT FOR NEWBORNS, AND HAVE ALSO SUGGESTED THAT THERE SHOULD BE A MORE CONSERVATIVE SET OF VACCINE RECOMMENDATIONS FOR THE COVID 19 SHOT, REGARDLESS OF WHAT THAT PANEL RECOMMENDS. ULTIMATELY, THE ACTING CDC DIRECTOR, JIM O’NEILL, WILL NEED TO SIGN OFF BEFORE THEY BECOME OFFICIAL LIVE ON CAPITOL HILL. I’M JACKIE DEFUSCO, KCRA THREE NEWS. JACKIE, THANK YOU. AND CLOSER TO HOME, CALIFORNIA LEADERS TODAY CONTINUE TO DISTANCE THE STATE FROM THE CDC WITH A SERIES OF ANNOUNCEMENTS. KCRA THREE POLITICAL DIRECTOR ASHLEY ZAVALA EXPLAINS THE ACTION GOVERNOR GAVIN NEWSOM TOOK TODAY. WELL, THIS COMES AS THE STATE CONTINUES TO CLASH WITH THE FEDERAL GOVERNMENT OVER VACCINES AND SCIENCE. OVERALL. TODAY, NEWSOM, ALONGSIDE THE GOVERNORS OF OREGON, WASHINGTON AND HAWAII, ROLLED OUT THEIR OWN VACCINE RECOMMENDATIONS FOR THE WINTER. THE GROUP IS ALSO NOW KNOWN AS THE WEST COAST HEALTH ALLIANCE. AS OF A COUPLE OF WEEKS AGO, THE RECOMMENDED SHOTS INCLUDE THE COVID 19 SHOT, FLU AND RSV SHOTS. THE GOVERNOR TODAY ALSO SIGNED A NEW STATE LAW THAT ALLOWS CALIFORNIA TO TAKE VACCINE RECOMMENDATIONS FROM MEDICAL GROUPS OUTSIDE OF THE CDC. THIS COMES AFTER ROBERT F KENNEDY JR FIRED ALL 17 MEMBERS OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES AND REPLACE THEM WITH VACCINE SKEPTICS. THE TRUMP ADMINISTRATION LOOSENED RECOMMENDATIONS AROUND THE COVID 19 VACCINE. ALSO IN A STATEMENT, THE WEST COAST GOVERNOR SAID, OUR STATES ARE UNITED IN PUTTING SCIENCE, SAFETY AND TRANSPARENCY FIRST AND IN PROTECTING FAMILIES WITH CLEAR, CREDIBLE VACCINE GUIDANCE. THE WEST COAST HEALTH ALLIANCE STANDS UNITED IN PROTECTING PUBLIC HEALTH AND ALWAYS PUTTING SAFETY BEFORE POLITICS. MEANWHILE, A SPOKESPERSON FOR THE U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES SAID DEMOCRAT RUN STATES THAT PUSHED UNSCIENTIFIC SCHOOL LOCKDOWNS, TODDLER MASK MANDATES AND DRACONIAN VACCINE PASSPORTS DURING THE COVID ERA COMPLETELY ERODED THE AMERICAN PEOPLE’S TRUST IN PUBLIC HEALTH AGENCIES. ACIP REMAINS THE SCIENTIFIC BODY GUIDING IMMUNIZATION RECOMMENDATIONS IN THIS COUNTRY. AND HHS WILL ENSURE POLICY IS BASED ON RIGOROUS EVIDENCE AND GOLD STANDARD SCIENCE, NOT THE FAILED POLITICS OF THE PANDEMIC. END QUOTE. NOW, SEPARATELY FROM THE GOVERNOR’S ANNOUNCEMENT TODAY, SOME DEMOCRATIC STATE LAWMAKERS AND LABOR GROUPS LAUNCHED AN EFFORT THAT WOULD ESSENTIALLY CREATE CALIFORNIA’S OWN CDC AND FOUNDATION FOUNDATION TO FUND MEDICAL RESEARCH. THIS WOULD FIRST NEED TO PASS AT THE STATE CAPITOL, THOUGH, BEFORE GOING TO VOTERS IN A BALLOT MEASURE IN NOVEMBER OF 2026. SO HOW MUCH MONEY ARE THEY EXPECTING TO SPEND ON THIS PROPOSAL? YEAH, ESSENTIALLY THEY’RE GOING TO ASK CALIFORNIA VOTERS TO APPROVE A MEASURE THAT WOULD INVOLVE BORROWING $23 BILLION IN BONDS. WE WILL HAVE A LOT MORE ON THIS AT FIVE. A LOT OF QUESTIONS AROUND THA

    California’s Democratic leaders on Wednesday announced a series of efforts to distance the state from President Donald Trump’s Centers for Disease Control and Prevention as the state and federal government continue to clash over vaccines and science. Gov. Gavin Newsom on Wednesday signed legislation that allows the state to set future immunization guidance on credible, independent medical organizations instead of the CDC. Those organizations could include but are not limited to the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, and the American Academy of Family Physicians. Also on Wednesday, the governor and the California Department of Public Health, along with other West Coast governors, rolled out vaccine recommendations for the upcoming winter, countering advice from the CDC. The recommendations include the COVID-19 shot, flu shot, and RSV vaccine. It comes two weeks after the leaders of California, Oregon, Washington and Hawaii established the West Coast Health Alliance to rebuke the Trump administration’s policies. States typically follow guidance from the CDC, but the Democratic leaders established the alliance after U.S. Health and Human Services Secretary Robert F. Kennedy Jr. fired all 17 members of the federal panel that advises on immunization practices and replaced them with vaccine skeptics. “Our states are united in putting science, safety, and transparency first — and in protecting families with clear, credible vaccine guidance. The West Coast Health Alliance stands united in protecting public health and always putting safety before politics,” the governors said in a joint statement. Separately from Newsom’s announcement Wednesday, labor groups and some California lawmakers announced an effort to try to establish their own CDC and foundation to fund medical research. The proposal specifically would involve borrowing $23 billion in bonds. The legislation, known as Senate Bill 607, would first need to pass the state Legislature before giving voters the final say on the November ballot in 2026. “In communities across California, families are counting on science to deliver cures, protect our health, and prepare us for the challenges of the future,” said Assemblymember José Luis Solache, D-Lynwood. “Donald Trump’s cuts threaten not just research, but the lives of our loved ones. This measure makes clear that Californians will take control of our future and invest in life-saving research – because our families, our health, and our economy are too important to leave in the hands of Washington politicians playing games with people’s lives.””Democrat-run states that pushed unscientific school lockdowns, toddler mask mandates, and draconian vaccine passports during the COVID era completely eroded the American people’s trust in public health agencies,” a statement from the U.S. Department of Health and Human Services read. “ACIP remains the scientific body guiding immunization recommendations in this country, and HHS will ensure policy is based on rigorous evidence and Gold Standard Science, not the failed politics of the pandemic.” See more coverage of top California stories here | Download our app | Subscribe to our morning newsletter | Find us on YouTube here and subscribe to our channel

    California’s Democratic leaders on Wednesday announced a series of efforts to distance the state from President Donald Trump’s Centers for Disease Control and Prevention as the state and federal government continue to clash over vaccines and science.

    Gov. Gavin Newsom on Wednesday signed legislation that allows the state to set future immunization guidance on credible, independent medical organizations instead of the CDC. Those organizations could include but are not limited to the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, and the American Academy of Family Physicians.

    Also on Wednesday, the governor and the California Department of Public Health, along with other West Coast governors, rolled out vaccine recommendations for the upcoming winter, countering advice from the CDC. The recommendations include the COVID-19 shot, flu shot, and RSV vaccine.

    It comes two weeks after the leaders of California, Oregon, Washington and Hawaii established the West Coast Health Alliance to rebuke the Trump administration’s policies. States typically follow guidance from the CDC, but the Democratic leaders established the alliance after U.S. Health and Human Services Secretary Robert F. Kennedy Jr. fired all 17 members of the federal panel that advises on immunization practices and replaced them with vaccine skeptics.

    “Our states are united in putting science, safety, and transparency first — and in protecting families with clear, credible vaccine guidance. The West Coast Health Alliance stands united in protecting public health and always putting safety before politics,” the governors said in a joint statement.

    Separately from Newsom’s announcement Wednesday, labor groups and some California lawmakers announced an effort to try to establish their own CDC and foundation to fund medical research. The proposal specifically would involve borrowing $23 billion in bonds.

    The legislation, known as Senate Bill 607, would first need to pass the state Legislature before giving voters the final say on the November ballot in 2026.

    “In communities across California, families are counting on science to deliver cures, protect our health, and prepare us for the challenges of the future,” said Assemblymember José Luis Solache, D-Lynwood. “Donald Trump’s cuts threaten not just research, but the lives of our loved ones. This measure makes clear that Californians will take control of our future and invest in life-saving research – because our families, our health, and our economy are too important to leave in the hands of Washington politicians playing games with people’s lives.”

    “Democrat-run states that pushed unscientific school lockdowns, toddler mask mandates, and draconian vaccine passports during the COVID era completely eroded the American people’s trust in public health agencies,” a statement from the U.S. Department of Health and Human Services read. “ACIP remains the scientific body guiding immunization recommendations in this country, and HHS will ensure policy is based on rigorous evidence and Gold Standard Science, not the failed politics of the pandemic.”

    See more coverage of top California stories here | Download our app | Subscribe to our morning newsletter | Find us on YouTube here and subscribe to our channel

    [ad_2]

    Source link

  • Teen’s medical invention saves lives in seconds

    [ad_1]

    NEWYou can now listen to Fox News articles!

    What if stopping life-threatening bleeding could be as simple as injecting a gel? That’s the promise of TRAUMAGEL, a groundbreaking, plant-based bleeding control gel now being used by first responders across the country, including a metro Atlanta fire department that recently used it to save one of their own. 

    Developed by Cresilon CEO and co-founder Joe Landolina, TRAUMAGEL works in seconds to control bleeding from gunshot wounds and other traumatic injuries. It’s supplied in a compact 30-ml syringe and can be quickly applied in the field before a patient bleeds out, a risk responsible for more than 35% of all prehospital deaths.

    STANFORD RESEARCHERS DEVELOP ‘GAME-CHANGING’ STROKE TREATMENT THAT DOUBLES EFFECTIVENESS

    Sign up for my FREE CyberGuy Report
    Get my best tech tips, urgent security alerts, and exclusive deals delivered straight to your inbox. Plus, you’ll get instant access to my Ultimate Scam Survival Guide — free when you join my CyberGuy.com/Newsletter 

    A TRAUMAGEL GEL syringe sits in front of its package. (Cresilon)

    A medical breakthrough born in a winery lab

    The story behind TRAUMAGEL starts with a teenager in a winery lab. Joe Landolina, now CEO of Cresilon, developed the technology when he was just 17.

    “My grandfather was a retired chemist who owned a vineyard in upstate New York,” Landolina explains. “I would work alongside him in his winery laboratory every single day after school from a very young age. During that time, I developed a strong love for chemistry, especially plant-based chemistries from ingredients found in nature around me.”

    That love turned into research. “At the age of 17, I was experimenting with polymers extracted from the cell walls of algae and discovered a matrix that would instantly bond to living tissue,” he said.

    He took the idea to New York University’s business plan competition, and Cresilon was born. The company now operates out of a 55,000-square-foot biomanufacturing facility in Brooklyn with nearly 100 employees.

    TRAUMAGEL is a plant-based bleeding control gel.

    TRAUMAGEL works in seconds to control bleeding from severe injuries. (Cresilon)

    Real-world impact: Faster bleeding control in the field

    TRAUMAGEL is already changing how medics respond in high-pressure trauma situations.

    “TRAUMAGEL has impacted how we respond to traumatic injuries in any situation,” says Lt. David Kleiman of Cobb County Fire & Emergency Services. “In the past, with junctional injuries, like the neck, armpit, or groin, we were using traditional methods like digital pressure or wound packing. That required multiple crews and took time.

    “With TRAUMAGEL, we can administer a hemostatic agent that controls bleeding in seconds,” he continues. “Crews can move on to quicker assessments and treatments and get the patient to definitive care faster.”

    MAN’S DEADLY BRAIN CANCER TUMOR DISAPPEARS AFTER EXPERIMENTAL DRUG TRIAL

    How it saved a firefighter’s life

    In one recent case, a Cobb County firefighter was injured during a response at an abandoned house. He tripped on a hill, cut his hand on broken glass, and attempted to stop the bleeding himself. But it didn’t work.

    “He eventually realized he couldn’t control the bleeding and made his way back to the engine,” Kleiman recalls. “The crew noted that he was pale and sweaty and that his turnout gear was saturated in blood. Traditional methods failed, so they administered TRAUMAGEL. It instantly stopped the bleeding.”

    The firefighter was then treated for blood loss and fully recovered after surgery. 

    Joe Landolina, CEO of Cresilon, and his team are seen with Cobb County Fire & Emergency Services personnel.

    Cresilon CEO and co-founder Joe Landolina (center) and his team stand with Cobb County Fire & Emergency Services. (Cresilon)

    From fire departments to the Department of Defense

    Cresilon’s bleeding control gel is being tested in even more demanding environments.

    “In addition to getting TRAUMAGEL into the hands of all first responders across the country,” Landolina says, “our proprietary technology is being studied for broader applications by the U.S. Defense Department’s Walter Reed Army Institute of Research.”

    That study is focused on penetrating traumatic brain injuries (TBI). “Preliminary findings demonstrated promising results in the ability of our technology to control bleeding and provide neuroprotection following a TBI,” he says. The team plans to pursue further research based on those results. 

    What this means for you

    Severe bleeding is the number one cause of preventable death from trauma. With TRAUMAGEL, emergency teams can control that bleeding quickly, even before a patient reaches the hospital. This tool isn’t just for battlefield medicine or professional EMS. In the future, you could see it in hospitals, dental offices, and even home first-aid kits. TRAUMAGEL may become a new standard in emergency bleeding control, and that means faster care, better outcomes, and more lives saved.

    Take my quiz: How safe is your online security?

    Think your devices and data are truly protected? Take this quick quiz to see where your digital habits stand. From passwords to Wi-Fi settings, you’ll get a personalized breakdown of what you’re doing right — and what needs improvement. Take my Quiz here: CyberGuy.com/Quiz

    CLICK HERE TO GET THE FOX NEWS APP

    Kurt’s key takeaways

    From a teenager’s lab experiment to a life-saving tool trusted by fire departments, TRAUMAGEL is reshaping trauma response. It’s fast, effective, and easy to use, exactly what first responders need when time is running out. As more ambulances, hospitals, and emergency personnel adopt the gel, its potential in saving lives continues to grow.

    Should every fire department in the U.S. carry this gel? Would you want TRAUMAGEL in your home first-aid kit? Let us know by writing to us at CyberGuy.com/Contact

    Sign up for my FREE CyberGuy Report
    Get my best tech tips, urgent security alerts, and exclusive deals delivered straight to your inbox. Plus, you’ll get instant access to my Ultimate Scam Survival Guide — free when you join my CyberGuy.com/Newsletter

    Copyright 2025 CyberGuy.com. All rights reserved.  

    [ad_2]

    Source link